TSO3 Inc., an innovator in sterilization technology for medical devices in healthcare settings, joins with Altru Health System in announcing the U.S. terminal sterilization of long, flexible gastrointestinal endoscopes, like the duodenoscope, using TSO3’s STERIZONE technology.

“Being the inaugural facility to offer terminal sterilization of endoscopes using the TSO3 technology, provides our patients with a level of safety above current best-practice standards in the industry,” says Stacie Avdem, Director of Surgical and Procedural Services at Altru Health System.

“Altru has achieved industry-leading practices with centralization, cleaning verification, and borescope inspection in endoscope reprocessing. The ability to sterilize endoscopes, specifically duodenoscopes, is paramount to achieving our mission of delivering world-class care to the residents of our region. It shows our ongoing investment in and commitment to patient safety,” says Jenni Gibbs, manager of central sterile department at Altru Health System.

In May, U.S. regulators approved TSO3’s most recent 510(k) submission for the terminal sterilization of multi-channeled flexible endoscopes using the company’s STERIZONE VP4 Sterilizer. The new clearance for the STERIZONE VP4 Sterilizer allows a hospital like Altru Health System to terminally sterilize gastrointestinal endoscopes that have dimensions within the cleared intended use.